Level Bio AB (publ) (NGM:LEVBIO)
Sweden
· Delayed Price · Currency is SEK 0.446
+0.016 (3.72%)
At close: Mar 6, 2026
Level Bio AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 32.36 | 25.1 | 26.1 | 34.33 | 43.96 | Upgrade
|
| Other Revenue | -0 | - | - | - | - | Upgrade
|
| Revenue | 32.36 | 25.1 | 26.1 | 34.33 | 43.96 | Upgrade
|
| Revenue Growth (YoY) | 28.94% | -3.83% | -23.99% | -21.91% | 86.86% | Upgrade
|
| Cost of Revenue | 15.31 | 11.6 | 13.79 | 19.08 | 26.08 | Upgrade
|
| Gross Profit | 17.06 | 13.49 | 12.31 | 15.25 | 17.88 | Upgrade
|
| Selling, General & Admin | 18.24 | 19.6 | 20.33 | 15.87 | 12.05 | Upgrade
|
| Other Operating Expenses | 0.11 | -0.21 | -0.48 | -0.46 | -0.69 | Upgrade
|
| Operating Expenses | 20.54 | 21.58 | 22.04 | 17.59 | 12.62 | Upgrade
|
| Operating Income | -3.49 | -8.08 | -9.73 | -2.33 | 5.26 | Upgrade
|
| Interest Expense | -0.08 | -0.13 | -0.01 | -0.08 | -0.04 | Upgrade
|
| Interest & Investment Income | - | 0.02 | 0.05 | 0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -3.57 | -8.19 | -9.69 | -2.41 | 5.21 | Upgrade
|
| Pretax Income | -3.57 | -8.19 | -9.69 | -2.41 | 5.21 | Upgrade
|
| Income Tax Expense | -0.03 | -0.32 | -0.22 | -0.19 | 0.06 | Upgrade
|
| Net Income | -3.54 | -7.87 | -9.48 | -2.22 | 5.16 | Upgrade
|
| Net Income to Common | -3.54 | -7.87 | -9.48 | -2.22 | 5.16 | Upgrade
|
| Net Income Growth | - | - | - | - | 240.69% | Upgrade
|
| Shares Outstanding (Basic) | 68 | 63 | 63 | 63 | 59 | Upgrade
|
| Shares Outstanding (Diluted) | 68 | 65 | 63 | 63 | 63 | Upgrade
|
| Shares Change (YoY) | 4.79% | 2.96% | - | - | 20.00% | Upgrade
|
| EPS (Basic) | -0.05 | -0.12 | -0.15 | -0.04 | 0.09 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.12 | -0.15 | -0.04 | 0.08 | Upgrade
|
| EPS Growth | - | - | - | - | 179.27% | Upgrade
|
| Free Cash Flow | 0.82 | -4.46 | -5.49 | 2.79 | 1.63 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.07 | -0.09 | 0.04 | 0.03 | Upgrade
|
| Gross Margin | 52.70% | 53.77% | 47.16% | 44.43% | 40.67% | Upgrade
|
| Operating Margin | -10.78% | -32.21% | -37.30% | -6.79% | 11.96% | Upgrade
|
| Profit Margin | -10.94% | -31.37% | -36.31% | -6.48% | 11.73% | Upgrade
|
| Free Cash Flow Margin | 2.53% | -17.78% | -21.03% | 8.14% | 3.70% | Upgrade
|
| EBITDA | -1.3 | -6.94 | -8.58 | -1.19 | 5.91 | Upgrade
|
| EBITDA Margin | -4.01% | -27.65% | -32.87% | -3.48% | 13.45% | Upgrade
|
| D&A For EBITDA | 2.19 | 1.14 | 1.15 | 1.14 | 0.65 | Upgrade
|
| EBIT | -3.49 | -8.08 | -9.73 | -2.33 | 5.26 | Upgrade
|
| EBIT Margin | -10.78% | -32.21% | -37.30% | -6.79% | 11.96% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 1.09% | Upgrade
|
| Revenue as Reported | 32.49 | 25.18 | 26.67 | 34.68 | 44.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.